Early Aubagio ‘preferable for preventing disease progression’
Early Aubagio reduces disability progression more significantly than delayed treatment in patients with multiple sclerosis (MS), according to results from the phase three TOWER study and its open-label extension phase, presented at the 2015 Annual Meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)... Read more - http://www.ms-uk.org/MSnews
Early Aubagio ‘preferable for preventing disease progression
Early Aubagio ‘preferable for preventing disease progression
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2797 Views
-
Last post by NHE
-
- 0 Replies
- 1300 Views
-
Last post by frodo
-
- 0 Replies
- 1364 Views
-
Last post by NHE
-
- 0 Replies
- 1369 Views
-
Last post by frodo
-
- 0 Replies
- 1531 Views
-
Last post by NHE
-
- 0 Replies
- 1245 Views
-
Last post by frodo
-
- 0 Replies
- 1613 Views
-
Last post by NHE
-
- 0 Replies
- 2024 Views
-
Last post by DIM
-
- 0 Replies
- 1139 Views
-
Last post by NHE